University Of Cologne
Clinical trials sponsored by University Of Cologne, explained in plain language.
-
Real-world study examines caplacizumab for aTTP: better treatment on the horizon?
Disease control OngoingThis study looks back at how doctors in Germany prescribed caplacizumab (Cablivi) for acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood clotting disorder. Researchers will analyze data from 350 patients to see how well the drug works outside of clinical trials and…
Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug combo aims to control myeloma without transplant
Disease control OngoingThis phase 2 trial tests daratumumab (Darzalex) combined with other drugs as a first treatment for multiple myeloma patients who are not eligible for a stem cell transplant. The goal is to see if this combination can achieve very good partial remission or better after 8 cycles, a…
Phase: PHASE2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could ChatGPT-Style AI help triage emergency patients? a massive study puts it to the test
Knowledge-focused OngoingThis study tests whether large language models (LLMs) — the same kind of AI behind chatbots — can predict what will happen to patients in the emergency department, such as whether they will be admitted to the hospital or need imaging. Researchers will analyze about 100,000 real e…
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC